Suppr超能文献

微小RNA-99b通过直接靶向NIPBL抑制非小细胞肺癌细胞的侵袭和迁移。

MicroRNA-99b inhibits NSCLC cell invasion and migration by directly targeting NIPBL.

作者信息

Xu J-X, Liu C-M, Ma C-P

机构信息

Weifang People's Hospital, Weifang, Shandong Province, P.R. China.

出版信息

Eur Rev Med Pharmacol Sci. 2021 Feb;25(4):1890-1898. doi: 10.26355/eurrev_202102_25084.

Abstract

OBJECTIVE

Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death worldwide. microRNAs (miRNAs) have been confirmed as vital regulators of multiple tumors, including NSCLC. The aim of the current study was to explore the biological mechanisms of miR-99b in NSCLC progression.

PATIENTS AND METHODS

NSCLC tissues and adjacent matched human non-neoplastic lung tissues used in this study were collected from 50 cases of NSCLC patients. The expression of miR-99b and NIPBL in NSCLC tissues and cell lines (A549, NCI-H460, NCI-H1299 and SPC-A1) were determined by real-time-polymerase chain reaction (qRT-PCR). The NIPBL protein level was measured by Western blot. Dual-Luciferase reporter, Western blotting and qRT-PCR were carried out to verify the potential target of miR-99b. Transwell assay was used for investigating miR-99b effect on cell migration and invasion in NSCLC cells.

RESULTS

The results of qRT-PCR indicated that the expression of miR-99b was downregulated in the NSCLC tissues and cell lines. Overexpression of miR-99b could significantly inhibit the invasion and migration capacities in NSCLC cells. Furthermore, we also determined that NIPBL was a direct target of miR-99b. Additionally, we found NIPBL was implicated in the suppressive effects on NSCLC cell invasion and migration mediated by miR-99b.

CONCLUSIONS

In summary, miR-99b exerted anti-tumor functions in NSCLC via regulation of NIPBL, suggesting that miR-99b/NIPBL axis may be novel biomarkers for NSCLC treatments.

摘要

目的

非小细胞肺癌(NSCLC)是全球癌症相关死亡的主要原因。微小RNA(miRNA)已被证实是包括NSCLC在内的多种肿瘤的重要调节因子。本研究的目的是探讨miR-99b在NSCLC进展中的生物学机制。

患者和方法

本研究中使用的NSCLC组织及相邻配对的人非肿瘤性肺组织取自50例NSCLC患者。通过实时聚合酶链反应(qRT-PCR)测定miR-99b和NIPBL在NSCLC组织和细胞系(A549、NCI-H460、NCI-H1299和SPC-A1)中的表达。通过蛋白质免疫印迹法测量NIPBL蛋白水平。进行双荧光素酶报告基因检测、蛋白质免疫印迹法和qRT-PCR以验证miR-99b的潜在靶标。采用Transwell实验研究miR-99b对NSCLC细胞迁移和侵袭能力的影响。

结果

qRT-PCR结果表明,miR-99b在NSCLC组织和细胞系中的表达下调。miR-99b的过表达可显著抑制NSCLC细胞的侵袭和迁移能力。此外,我们还确定NIPBL是miR-99b的直接靶标。此外,我们发现NIPBL参与了miR-99b介导的对NSCLC细胞侵袭和迁移的抑制作用。

结论

总之,miR-99b通过调节NIPBL在NSCLC中发挥抗肿瘤功能,提示miR-99b/NIPBL轴可能是NSCLC治疗的新型生物标志物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验